SCHEMBL1346259

SCHEMBL1346259

Cc1cc(CNCCC2C3CC4CC(C3)CC2C4)ccc1-c1cccc(C(N)=O)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 2/20 0.38
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
LRRK2 Q5S007 1/20 0.37
CD274 Q9NZQ7 1/20 0.37
ALDH2 P05091 1/20 0.36
SHMT1 P34896 1/20 0.36
ROCK2 O75116 3/20 0.36
ROCK1 Q13464 3/20 0.36
BAZ2B Q9UIF8 1/20 0.35
BAZ2A Q9UIF9 1/20 0.35
FAAH O00519 1/20 0.35
SMYD2 Q9NRG4 1/20 0.35
NR3C2 P08235 1/20 0.35
OPRM1 P35372 2/20 0.35
OPRD1 P41143 2/20 0.35
OPRK1 P41145 2/20 0.35
DGAT2 Q96PD7 1/20 0.35
SUCNR1 Q9BXA5 1/20 0.35
CSF1R P07333 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13929389 0.90 ROCK2 (0.36) KDM1AMAOAMAOBLRRK2CD274
SCHEMBL1346058 0.86 LMNA (0.38) KDM1AMAOAMAOBLRRK2CD274
SCHEMBL1347410 0.84 DHODH (0.42) KDM1AMAOAMAOBNR3C2
SCHEMBL1348506 0.82 OPRM1 (0.42) LRRK2SHMT1FAAHOPRM1OPRD1
SCHEMBL1347747 0.82 KDM1A (0.51) KDM1AMAOAMAOBCD274FAAH
SCHEMBL13928989 0.80 ALDH2 (0.36) LRRK2CD274ALDH2SHMT1ROCK2
SCHEMBL1347863 0.79 OPRM1 (0.52) CD274SHMT1ROCK1FAAHOPRM1
SCHEMBL1347921 0.79 OPRM1 (0.46) LRRK2CD274ALDH2SHMT1BAZ2B
SCHEMBL12651157 0.75 OPRM1 (0.58) KDM1AMAOAMAOBLRRK2ALDH2
SCHEMBL1790195 0.74 OPRM1 (0.41) SHMT1ROCK2ROCK1FAAHOPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8063247-B2 Bicyclic aryl and heteroaryl receptor modulators PROSIDION LIMITED (GB) 2011-11-22 US claimed
US-8063247-B2 Bicyclic aryl and heteroaryl receptor modulators PROSIDION LIMITED (GB) 2011-11-22 US disclosed
US-8063247-B2 Bicyclic aryl and heteroaryl receptor modulators PROSIDION LIMITED (GB) 2011-11-22 US disclosed
US-20100267780-A1 BICYCLIC ARYL AND HETEROARYL RECEPTOR MODULATORS PROSIDION LIMITED (GB) 2010-10-21 US disclosed
US-20100267780-A1 BICYCLIC ARYL AND HETEROARYL RECEPTOR MODULATORS PROSIDION LIMITED (GB) 2010-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267780-A1 BICYCLIC ARYL AND HETEROARYL RECEPTOR MODULATORS OPRM1, OPRL1, OPRD1 KDM1A 2408/4885MAOA 477/4885MAOB 528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.